Glenmark inks licensing pact with Jiangsu Alphamab, 3D Medic

Under the agreement, Glenmark will get the license for KN035 (Envafolimab) in India, Asia Pacific, the Middle East, Africa, Russia, CIS, and Latin America, the company said in a statement.

Related Keywords

China , Beijing , Russia , United States , India , America , Chinese , Jiangsu Alphamab , Tracon Pharma , Glenn Saldanha , Asia Pacific , Glenmark Pharmaceuticals , Jiangsu Alphamab Biopharmaceuticals Co , National Medical Products Administration Chinese , Drug Administration , Glenmark Pharmaceuticals Ltd On , D Medicines Beijing Co Ltd , Pharmaceuticals Ltd , Middle East , Latin America , Pharmaceuticals Chairman , Managing Glenn Saldanha , National Medical Products Administration , Biliary Tract , Business , Companies , Glenmark Pharma ,